This work was funded by the University of St Andrews and Society for Applied Microbiology New Lecturer Research Grant awarded to CSA, Wellcome Trust grant (093228) awarded to TKS.HIV-1 maturation inhibitors are a novel class of antiretroviral compounds, which consist of two structurally distinct chemical classes; betulinic acid derivatives and the pyridone-based compound PF-46396. It is currently believed that both classes act by a similar mode of action to generate aberrant non-infectious particles via inhibition of CA-SP1 cleavage during Gag proteolytic processing. In this study we utilized a series of novel analogues, with decreasing similarity to PF-46396, to determine the chemical groups within PF-46396 that contribute to antiviral act...
Despite the major role of Gag in establishing resistance of HIV-1 to protease inhibitors (PIs), very...
Four HIV-1 protease (PR) inhibitors, clinical inhibitors lopinavir and tipranavir, and two investiga...
Treatment of the HIV-1 Gag precursor by the viral protease after release of the viral particle allow...
HIV-1 maturation inhibitors are a novel class of antiretroviral compounds, which consist of two stru...
HIV-1 maturation inhibitors are a novel class of antiretroviral compounds, which consist of two stru...
<div><p>Processing of the Gag precursor protein by the viral protease during particle release trigge...
Abstract3-O-(3′,3′-dimethylsuccinyl) betulinic acid, also termed PA-457 or DSB, is a novel HIV-1 inh...
Despite the effectiveness of currently available human immunodeficiency virus type 1 (HIV-1) therapi...
Despite the effectiveness of currently available human immunodeficiency virus type 1 (HIV-1) therapi...
AbstractDespite significant advances in antiretroviral therapy, increasing drug resistance and toxic...
Under the selective pressure of protease inhibitor therapy, patients infected with human immunodefic...
The human immunodeficiency virus type 1 (HIV-1) protease (PR) makes five obligatory cleavages in the...
AbstractRegions of HIV-1 gag between p2 and p6Gag/p6Pol, in addition to protease (PR), develop genet...
Treatment of the HIV-1 Gag precursor by the viral protease after release of the viral particle allow...
Despite the major role of Gag in establishing resistance of HIV-1 to protease inhibitors (PIs), very...
Despite the major role of Gag in establishing resistance of HIV-1 to protease inhibitors (PIs), very...
Four HIV-1 protease (PR) inhibitors, clinical inhibitors lopinavir and tipranavir, and two investiga...
Treatment of the HIV-1 Gag precursor by the viral protease after release of the viral particle allow...
HIV-1 maturation inhibitors are a novel class of antiretroviral compounds, which consist of two stru...
HIV-1 maturation inhibitors are a novel class of antiretroviral compounds, which consist of two stru...
<div><p>Processing of the Gag precursor protein by the viral protease during particle release trigge...
Abstract3-O-(3′,3′-dimethylsuccinyl) betulinic acid, also termed PA-457 or DSB, is a novel HIV-1 inh...
Despite the effectiveness of currently available human immunodeficiency virus type 1 (HIV-1) therapi...
Despite the effectiveness of currently available human immunodeficiency virus type 1 (HIV-1) therapi...
AbstractDespite significant advances in antiretroviral therapy, increasing drug resistance and toxic...
Under the selective pressure of protease inhibitor therapy, patients infected with human immunodefic...
The human immunodeficiency virus type 1 (HIV-1) protease (PR) makes five obligatory cleavages in the...
AbstractRegions of HIV-1 gag between p2 and p6Gag/p6Pol, in addition to protease (PR), develop genet...
Treatment of the HIV-1 Gag precursor by the viral protease after release of the viral particle allow...
Despite the major role of Gag in establishing resistance of HIV-1 to protease inhibitors (PIs), very...
Despite the major role of Gag in establishing resistance of HIV-1 to protease inhibitors (PIs), very...
Four HIV-1 protease (PR) inhibitors, clinical inhibitors lopinavir and tipranavir, and two investiga...
Treatment of the HIV-1 Gag precursor by the viral protease after release of the viral particle allow...